Search results
Women with epilepsy face a rollercoaster of hormones and seizures. But we’re treating them like men
The Conversation· 13 hours agoAbout 50 million people globally have epilepsy. Until now, treatments for men and women have been identical. For women, fluctuating hormones – spanning ...
New cell therapy may control epilepsy
WINK TV Southwest Florida· 20 hours agoNow, a new clinical trial for epilepsy is using a regenerative brain cell procedure to stop seizures. Standard epilepsy treatment ...
My son needed brain surgery to stop his seizures. Even though I'm his mom, I had a hard time making...
INSIDER via Yahoo News· 3 days agoWhen he was nearing the maximum dosages, doctors explained that we might need to consider other...
Precision laser surgery cuts focal epileptic seizure spread
Medical Xpress· 7 days agoLieberman would later witness a second seizure—ironically involving a professor giving a lecture on...
Letter to editor and response: Is neurocysticercos | Newswise
Newswise· 6 days agoILAE produced a podcast episode in 2023 in which Dr. Hector Garcia talked about neurocysticercosis...
'We didn't recognise the signs of epilepsy,' family says
BBC via AOL· 3 days agoepilepsy live with seizures that do not respond to medication. In 65% of cases, the cause of a person’s epilepsy remains unknown. More ...
Epilepsy Doctor: Chiefs Player BJ Thompson Could Return To Football
Forbes· 2 days agoBJ Thompson went into cardiac arrest during a special teams meeting last week. “There wouldn’t be...
Dravet Syndrome: 'Our boy had multiple seizures before diagnosis'
BBC News· 1 day agoA mum and dad, from Ashford, who found their young son "foaming at the mouth" want to raise...
J&J-backed Rapport Therapeutics valued at $636.8 million in lukewarm debut
Reuters via Yahoo News· 6 days agoU.S. IPOs are seeing a rebound this year, after an almost two-year dry spell when high interest rates, market volatility and geopolitical turmoil marred investors' risk appetite. Among other ...
Earnings call: Addex Therapeutics reports on Q1 2024 with mixed results By Investing.com
Investing.com· 7 days agoThe company announced progress in their GABAB positive allosteric modulator program, with a...
